☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Sierra Oncology
Barbara Klencke, CMO at Sierra Oncology (now GSK) Shares Insights on the Significant benefits obtained from the Pivotal Myelofibro...
July 18, 2022
PharmaShots Weekly Snapshots (June 13– 17, 2022)
June 17, 2022
Sierra Oncology Reports NDA Submission of Momelotinib to the US FDA for the Treatment of Myelofibrosis
June 17, 2022
Sierra Oncology Reports Results of Momelotinib in P-III (MOMENTUM) Study for the Treatment of Myelofibrosis
January 27, 2022
PharmaShots Interview: Sierra Oncology Dr. Barbara Klencke Shares Insight on Sierra's Agreement with AstraZeneca for AZD5153
October 11, 2021
PharmaShots Weekly Snapshot (November 04-08, 2019)
November 11, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.